Latest NBIX Analyst Ratings & Recommendations
Recent analyst recommendations with rating changes and price target updates (last 90 days)
| Date | Analyst | Firm | Action | Rating | Price Target |
|---|---|---|---|---|---|
| Laura Chico | Wedbush | Maintains | Buy | $176.00 → $185.00 +9.00 (5.1%) | |
| Danielle Brill | Truist | Maintains | Buy | $155.00 → $200.00 +45.00 (29.0%) | |
| Evan Seigerman | BMO Capital | Maintains | Hold | $144.00 → $170.00 +26.00 (18.1%) | |
| Danielle Brill | Truist | Maintains | Buy | - | |
| Brian Abrahams | RBC Capital | Maintains | Buy | $183.00 → $195.00 +12.00 (6.6%) | |
| Unknown Analyst | Jefferies | Maintains | Buy | $200.00 | |
| Ashwani Verma | UBS | Maintains | Buy | $182.00 → $208.00 +26.00 (14.3%) | |
| Unknown Analyst | Jefferies | Maintains | Buy | $181.00 | |
| Yigal Nochomovitz | Citi | Maintains | Buy | $246.00 | |
| Myles Minter | William Blair | Reiterates | Buy | - | |
| Corinne Johnson | Goldman Sachs | Initiates | Buy | $213.00 | |
| OpenAI Biotechnology | TipRanks - OpenAI | Reiterates | Buy | $185.00 → $184.00 -1.00 (-0.5%) | |
| Brian Abrahams | RBC Capital | Maintains | Buy | $180.00 → $183.00 +3.00 (1.7%) |
